ArticleCancers2022

Molecular Targets in Lung Cancer: Study of the Evolution of Biomarkers Associated with Treatment with Tyrosine Kinase Inhibitors-Has NF1 Tumor Suppressor a Key Role in Acquired Resistance?

Begoña O Alen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.